Feedback / Questions
eblasakimab (ASLAN004) - ASLAN Pharma
https://www.globenewswire.com/news-release/2022/01/20/2370569/0/en/ASLAN-Pharmaceuticals-Initiates-Phase-2b-Study-of-ASLAN004-Eblasakimab-in-Moderate-to-Severe-Atopic-Dermatitis.html
Jan 20, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next